IDStewardship

MAY 13, 2023

In this article an infectious diseases pharmacists discusses the MAD-ID conference, which is known as The Antimicrobial Stewardship Meeting, Making A Difference In Infectious Diseases (MAD-ID). Scroll to the bottom of this post for a list of infectious diseases meetings that have been sourced from Twitter.

Communication 130

Communication 130

Pharmafile

APRIL 18, 2024

Full results from the EAGLE-1 trial are expected to be presented at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) taking place […] The post GSK shares results from phase 3 trial for gonorrhoea treatment appeared first on Pharmafile.

64

64

European Pharmaceutical Review

OCTOBER 4, 2023

This follows the WHO’s recommendation of the RTS,S/AS01 vaccine for the disease in 2021. The World Health Organization ( WHO ) has recommended a new vaccine, R21/Matrix-M, to prevent malaria in children. The R21 vaccine is the second malaria vaccine recommended by WHO.

Vaccines 105

Vaccines 105

IDStewardship

APRIL 14, 2024

rCDI is defined as clinically significant diarrhea and a positive test confirming CDI within eight weeks of completing treatment for CDI. Of note, patients with inflammatory bowel disease or other gastrointestinal comorbidities receiving immunosuppressants may experience flares in their disease after undergoing FMT.

FDA 324

FDA Hospitals Communication 324

European Pharmaceutical Review

AUGUST 21, 2023

According to a market report , the global RNA therapy clinical trials market is anticipated to reach $3.5 This has therefore led to a rise in the number of RNA clinical trials being conducted. This has also resulted in the pharmaceutical industry investigating RNA as a target to treat other infectious diseases and oncology indications.

Vaccines 95

Vaccines 95

IDStewardship

OCTOBER 10, 2022

In this article a pharmacist with specialized training in infectious diseases discusses five key areas of study to master in the field of antimicrobial pharmacotherapy, to become an antibiotic ninja. It is commonplace for learners such as students and residents to struggle with infectious diseases pharmacotherapy.

226

226

IDStewardship

AUGUST 29, 2022

In this short special interest piece, an infectious disease pharmacists who went viral with one of his social media posts is interviewed. Given pharmacists are not commonly going viral on social media, it seemed like a fun and interesting thing to interview this infectious diseases pharmacist about his experience.

Hospitals 130

Hospitals 130

Pharmacy Is Right For Me

AUGUST 10, 2022

Dr. Brown is the National Field Director for Janssen Infectious Diseases & Vaccines. Medical Affairs, Infectious Diseases, where I worked on both the HCV and HIV clinical teams, leading efforts on research trials, as well as product launch activities. Today we’re excited to spotlight Kimberley Brown, Pharm.D.!

Vaccines 130

Vaccines Pharmaceutical Companies Pharmaceutical Companies 130

IDStewardship

DECEMBER 30, 2022

The Learn Antibiotics book is for all teachers and learners of infectious diseases. The Learn Antibiotics book can be used to brush up on infectious diseases knowledge or as a resource for preceptors to use with their learners. It has been reviewed for content accuracy by two other infectious diseases pharmacists.

130

130

European Pharmaceutical Review

APRIL 18, 2024

More about the EAGLE-1 trial for the antibiotic gepotidacin The global phase III clinical programme for gepotidacin in adults and adolescents involved three clinical trials. GSK shared that the safety and tolerability profile of gepotidacin in this trial was consistent with data seen in Phase I and II trials.

102

102

Pharmaceutical Technology

MARCH 28, 2023

Following on from its Covid-19 vaccine programmes, BioNTech has set its sights on a range of infectious diseases for vaccine development. In its FY 2022 report, BioNTech has identified herpes simplex virus (HSV), malaria, and shingles as disease targets.

Vaccines 110

Vaccines 110

IDStewardship

SEPTEMBER 2, 2022

In this article an expert in clinical information design provides his insights, discussing reasons why some guidelines do not get used along with solutions to these problems. I recently had the opportunity to meet and speak with Dr. Michael Long, who is an expert in clinical information design. Interview with: Michael Long, Ph.D.

Hospitals 130

Hospitals Documentation Formulary Information Medication Guidelines 130

Pharmafile

MARCH 22, 2023

Published date: 22/03/2023 Summary: VANCOUVER, British Columbia & LONDON, March 22, 2023 – AbCellera (Nasdaq: ABCL) and RQ Bio announced today that they have entered into a strategic collaboration to identify optimal clinical candidates for up to three infectious disease targets selected by RQ Bio, including influenza and cytomegalovirus (CMV).

52

52

Board Vitals - Pharmacist

JANUARY 24, 2024

Cardiovascular Disease In 2023, the pass rate for first-time test takers remained level, with 86% of takers passing the exam. Infectious Disease The Infectious Disease board exam saw a slight increase in pass rates, going from 94% in 2022 to 96% in 2023. Don’t become complacent.

101

101

STAT

JANUARY 19, 2023

As it looks to curb the spread of infectious diseases, the Gates Foundation is lending its support to an effort to use artificial intelligence to make it easier for health providers in India and Nigeria to quickly diagnose certain conditions.

100

100

European Pharmaceutical Review

MAY 19, 2023

The ATTACK trial was done at 59 clinical sites in 16 countries with adults aged 18 years or older. Mortality due to multiple causes after 28 days was 12 of 63 (19 percent) in the sulbactam–durlobactam group. In the colistin group, the mortality was 32 percent.

Hospitals 104

Hospitals FDA Medical Schools 104

STAT

SEPTEMBER 14, 2022

These trade-offs aren’t limited to the clinical world. For half a decade, I oversaw a clinical trial testing a new vaccine against the hepatitis C virus, a slowly progressing and usually silent infectious disease that damages the liver over decades, and can cause cancer and even death.

Vaccines 98

Vaccines Chemotherapy 98

IDStewardship

DECEMBER 26, 2022

This Infectious Diseases Pharmacist Went Viral On Social Media – You’ll Never Guess Why. Insights On Designing Useful Guidelines For Infectious Diseases. The Top 100 Twitter Influencers in Infectious Diseases. Infectious Microbes & Diseases. Michael Bosco, Pharm.D., BCIDP, AAHIVP.

Chemotherapy 130

Chemotherapy Hospitals 130

European Pharmaceutical Review

JUNE 27, 2022

The European Commission (EC) has launched the Healthier Together: EU Non-communicable diseases (NCDs) initiative to support EU Member States in reducing the burden of NCDs by addressing the leading causes of avoidable premature death in Europe and improving citizens’ health and well-being. Europe’s Healthier Together initiative.

Vaccines 98

Vaccines Communication Documentation Compounding 98

European Pharmaceutical Review

NOVEMBER 29, 2022

National Institute for Health and Care Research (NIHR)’s Clinical Research Network. It will also involve experts in infectious diseases and virology who will monitor the flu virus to see if it becomes resistant to the anti-viral drugs tested in the trial.

Hospitals 102

Hospitals Vaccines 102

Pharmacy Is Right For Me

DECEMBER 14, 2023

Dr. Small is a pediatric clinical pharmacist specialist but if you had asked him years earlier, he would not have thought that he would end up working with children, “Pediatrics was actually the only specialty I intentionally avoided in pharmacy school due to my fear that I would make a medication error and harm a child.”

Hospitals 162

Hospitals 162

Pharmaceutical Commerce

FEBRUARY 7, 2023

The new $43M plasmid manufacturing facility will support both clinical and commercial production in the cancer and infectious disease spaces.

52

52

European Pharmaceutical Review

JANUARY 19, 2024

According to GlobalData, with demonstrated efficacy against carbapenem-resistant Acinetobacter Baumanni (CRAB), Roche’s zosurabalpin “has the potential to treat lethal hospital infection,” Anaelle Tannen, Infectious Disease Analyst at GlobalData explained. An example is Fetroja (cefiderocol sulfate tosylate).

Hospitals 95

Hospitals 95

European Pharmaceutical Review

MARCH 26, 2024

“We are excited to announce our fourth infectious disease vaccine programme with positive Phase III data,” stated Stéphane Bancel, Chief Executive Officer of Moderna. These findings were based on data comparing the treatment to mRNA-1273.222 (Spikevax ® ), Moderna’s licensed vaccine for the condition.

Vaccines 97

Vaccines Immunization 97

Pharmafile

MARCH 31, 2023

All will continue to work with partners in order to move forward with preclinical and clinical development in the infectious diseases and oncology fields. Japan-based NEC Corporation has announced that it is realigning its subsidiaries in order to streamline its AI drug development services. read more

Communication 52

Communication 52

European Pharmaceutical Review

APRIL 28, 2023

The initiative will help to improve clinical decision-making regarding antimicrobial use and also inform practices and guidelines for prescribers, users and policymakers. Researchers will work to build knowledge in optimal antibiotics use, improved access to effective treatment and better prevention and treatment of bacterial infections.

95

95

Fuld

NOVEMBER 29, 2022

A leading manufacturer of multiple infectious disease vaccines used Fuld & Company’s competitive monitoring services to gain a clear view of the evolving competitive landscape. ? Fuld & Company conducted monthly monitoring and intelligence gathering in a variety of infectious disease areas each year.

Vaccines 52

Vaccines 52

IDStewardship

JUNE 1, 2023

There have been multiple guidelines on antimicrobial stewardship published by the Infectious Disease Society of America. There are Core Elements on antimicrobial stewardship that the Centers for Disease Control and Prevention (CDC) has published for hospitals, outpatient, nursing homes, and limited-resource settings.

Hospitals 131

Hospitals Nursing Homes Communication Medical Schools 131

pharmaphorum

JANUARY 6, 2023

The cancer immunotherapies will mainly be provided in the context of clinical trials over the alliance, which extends out to 2030, but also covers supply of commercial therapies if approved in the interim. It will also cover some infectious disease targets. ” Image via @BioNTech_Group twitter.

Vaccines 110

Vaccines Immunization 110

pharmaphorum

JULY 7, 2022

In the second of a three-part series, Ben Hargreaves looks at the importance of early-stage research into various emerging infectious disease threats and how it saved precious time in the work to develop a working vaccine during the current pandemic. Research defence.

Vaccines 104

Vaccines Immunization 104

Pharmaceutical Technology

JUNE 24, 2022

GlaxoSmithKline (GSK) has announced plans to invest $1.2bn (£1bn) over a decade to expedite research and development (R&D) for infectious diseases in lower-income countries. These ailments are said to account for over 60% of the disease burden in several lower-income countries.

Vaccines 59

Vaccines 59

Roots Analysis

MARCH 13, 2024

However, it is important to note that, currently, the approved antiviral medications (around 80) are capable of targeting only 10 of the 220 known viruses that are responsible for causing multiple life threatening infectious diseases in humans.

40

40

pharmaphorum

NOVEMBER 20, 2022

COVID-19 set new expectations for how quickly R&D can move; the Coalition for Epidemic Preparedness Innovations (CEPI) has since established a 100 Days Mission for responding to the next Disease X, but what needs to happen for this to become a reality? New hurdles from COVID-19 vaccine development.

Vaccines 98

Vaccines Immunization 98

Pharmafile

DECEMBER 23, 2022

The aim of the partnership is to generate a ready supply of UK-produced mRNA vaccines for COVID-19 and other infectious diseases like flu and respiratory syncytial virus (RSV). read more.

Vaccines 64

Vaccines 64

pharmaphorum

MARCH 2, 2021

With pandemic vaccines now launching at record speeds, the first Genetic Vaccine Development for Infectious Diseases Summit will focus on overcoming the translational and clinical challenges of developing genetic vaccines targeting infectious diseases, including Influenza , Lassa Fever , Ebola , MERS , HIV , Zika , and COVID-19.

Vaccines 52

Vaccines 52

Pharmafile

JANUARY 26, 2023

Published date: 26/01/2023 Summary: Paris, France and Eastleigh, UK – 26 January 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an unaudited trading update for the year ended 31 December 2022.

40

40

European Pharmaceutical Review

JULY 7, 2022

” Since September 2021, Dr Hughes has been Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals, based in Boston. .” ” Since September 2021, Dr Hughes has been Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals, based in Boston.

Research Laboratories 93

Research Laboratories Pharmaceutical Companies Pharmaceutical Companies Hospitals 93